Leukaplasmapheresis in meningococcal septic shock

This publication has 10 references indexed in Scilit:

• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
  Blood, 1990
• Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal Subjects
  New England Journal of Medicine, 1989
• Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells.
  The Journal of Immunology, 1989
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
  The Journal of Experimental Medicine, 1989
• Functional discrimination between interleukin 6 and interleukin 1
  European Journal of Immunology, 1988
• A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock
  New England Journal of Medicine, 1987
• Prognostic factors of severe infectious purpura in children
  Intensive Care Medicine, 1985
• Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
  Journal of Clinical Investigation, 1985
• Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.
  BMJ, 1984
• Prognostic Factors in Meningococcal Disease
  Scandinavian Journal of Infectious Diseases, 1971